MONTIRONI, Rodolfo
 Distribuzione geografica
Continente #
NA - Nord America 43.798
EU - Europa 20.591
AS - Asia 20.229
SA - Sud America 5.541
AF - Africa 936
Continente sconosciuto - Info sul continente non disponibili 56
OC - Oceania 21
AN - Antartide 1
Totale 91.173
Nazione #
US - Stati Uniti d'America 43.149
SG - Singapore 6.378
BR - Brasile 4.376
VN - Vietnam 4.302
RU - Federazione Russa 3.935
UA - Ucraina 3.873
CN - Cina 2.421
IE - Irlanda 2.236
HK - Hong Kong 2.180
DE - Germania 2.057
TR - Turchia 2.004
SE - Svezia 1.808
IT - Italia 1.574
DK - Danimarca 1.436
FR - Francia 1.350
FI - Finlandia 974
KR - Corea 808
GB - Regno Unito 773
IN - India 453
AR - Argentina 408
BD - Bangladesh 330
CI - Costa d'Avorio 326
MX - Messico 267
CA - Canada 236
ID - Indonesia 214
EC - Ecuador 200
IQ - Iraq 193
ZA - Sudafrica 192
CO - Colombia 165
JP - Giappone 124
MA - Marocco 117
PK - Pakistan 109
NL - Olanda 103
VE - Venezuela 102
UZ - Uzbekistan 94
PL - Polonia 92
PH - Filippine 86
PY - Paraguay 84
CL - Cile 71
ES - Italia 70
SA - Arabia Saudita 66
BE - Belgio 57
EG - Egitto 56
EU - Europa 52
TN - Tunisia 52
PE - Perù 51
TH - Thailandia 49
JO - Giordania 48
UY - Uruguay 46
AT - Austria 39
KE - Kenya 38
MY - Malesia 38
DZ - Algeria 37
NP - Nepal 32
BO - Bolivia 31
AE - Emirati Arabi Uniti 28
AZ - Azerbaigian 28
KZ - Kazakistan 28
RO - Romania 27
LB - Libano 25
EE - Estonia 24
DO - Repubblica Dominicana 23
ET - Etiopia 23
HN - Honduras 23
OM - Oman 23
IL - Israele 21
AL - Albania 20
KG - Kirghizistan 20
TW - Taiwan 20
BH - Bahrain 18
CR - Costa Rica 17
PA - Panama 17
PS - Palestinian Territory 17
AU - Australia 16
BY - Bielorussia 14
RS - Serbia 14
SN - Senegal 14
CH - Svizzera 13
GR - Grecia 13
NG - Nigeria 13
AO - Angola 12
JM - Giamaica 12
AM - Armenia 11
NI - Nicaragua 11
TT - Trinidad e Tobago 11
BG - Bulgaria 10
CZ - Repubblica Ceca 10
GT - Guatemala 10
KW - Kuwait 9
LT - Lituania 9
LV - Lettonia 9
LY - Libia 9
MD - Moldavia 9
SY - Repubblica araba siriana 8
GA - Gabon 7
GE - Georgia 7
HU - Ungheria 7
PT - Portogallo 7
CG - Congo 6
IR - Iran 6
Totale 91.041
Città #
Ashburn 6.399
Singapore 3.976
Jacksonville 3.928
Chandler 3.293
Fairfield 3.237
Dallas 2.276
Dublin 2.230
Hong Kong 2.115
Boardman 2.074
Des Moines 1.840
Wilmington 1.770
Woodbridge 1.432
Ho Chi Minh City 1.412
Seattle 1.278
Houston 1.260
San Jose 1.228
Cambridge 1.006
Hanoi 966
The Dalles 945
New York 940
Lawrence 905
Princeton 905
San Mateo 890
Lauterbourg 811
Moscow 601
Ann Arbor 600
Beijing 553
Hefei 465
San Diego 423
Centro 416
Los Angeles 383
São Paulo 363
Abidjan 326
Milan 255
Da Nang 220
Munich 199
Haiphong 191
Helsinki 182
London 178
Buffalo 166
Chicago 161
Rio de Janeiro 141
Pune 132
Council Bluffs 130
Orem 130
Shanghai 109
Mexico City 101
Tokyo 100
Santa Clara 98
Norwalk 93
Washington 93
Guangzhou 91
Tashkent 87
Wuhan 86
Belo Horizonte 85
Warsaw 84
Johannesburg 79
Guayaquil 78
Turku 78
Curitiba 77
Brasília 76
Redmond 75
Biên Hòa 74
Izmir 72
Porto Alegre 71
Baghdad 67
Columbus 66
Frankfurt am Main 65
Falls Church 62
Brooklyn 60
Chennai 59
Montreal 59
Hải Dương 58
Denver 55
Quito 55
Can Tho 53
Rome 53
Salvador 53
Brussels 52
Dhaka 51
Salt Lake City 50
Vancouver 50
Campinas 48
Marche 48
Atlanta 47
Phoenix 47
Turin 47
Kilburn 44
Thái Bình 44
Thái Nguyên 44
Amman 43
Elk Grove Village 43
Jakarta 43
San Francisco 43
Cape Town 41
Manchester 40
Santiago 40
Stockholm 39
Bến Tre 37
Guarulhos 37
Totale 56.781
Nome #
Metabolic phenotype of bladder cancer 251
Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists. 246
Mitogen-activated protein kinases and apoptosis in PIN. 227
Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis 225
Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP). 225
Lymphoepithelioma-like carcinoma of the urinary bladder: a clinicopathologic study of 13 cases. 225
Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. 213
Immunotherapy in genitourinary cancers: Where are we going? 205
Prostatic Intraepithelial Neoplasia - Development of A Bayesian Belief Network For Diagnosis and Grading. 201
Designing novel immunocombinations in metastatic renal cell carcinoma 201
OCT4: biological functions and clinical applications as a marker of germ cell neoplasia 198
Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implications 194
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 190
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 190
2004 WHO classification of the renal tumors of the adults. 189
BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: Molecular diagnostics and possible targets for personalized therapies 187
Predicting future cancer burden in the United States by artificial neural networks 187
Transcontinental communication and quantitative digital histopathology via the Internet; with special reference to prostate neoplasia 181
D2-40 immunoreactivity in penile squamous cell carcinoma: a marker of aggressiveness 178
Clinical performance and utility of a NNMT-based urine test for bladder cancer 178
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. 177
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer 176
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications 176
Ciliary neurotrophic factor (CNTF) and its receptor (CNTFRα) signal through MAPK/ERK pathway in human prostate tissues: a morphological and biomolecular study 173
"Pathological" reflection on European urology: extended, saturation, and systematic prostate biopsies. 172
Re: Umberto Leone Roberti Maggiore, Simone Ferrero, Massimo Candiani, et al. Bladder Endometriosis: A Systematic Review of Pathogenesis, Diagnosis, Treatment, Impact on Fertility, and Risk of Malignant Transformation. Eur Urol 2017;71:790–807 171
Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in Renal Cell Carcinoma 170
Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer 170
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? 169
[International Society of Urological Pathology (ISUP) Consensus Conference on handling and staging of radical prostatectomy specimens]. 168
Cognitive zonal fusion biopsy of the prostate: Original technique between target and saturation. 167
Chromosomal Abnormalities in Macroscopically Normal Urothelium in Patiens with Bladder pT1 and pT2a Urothelial Carcinoma: a Fluorescence in situ hybridisation Study and Correlation with Histologic Features. 166
Secondary neoplasms of the urinary system and male genital organs. 165
Standardized mitotic counts in breast cancer evaluation of the method 165
Exploring the Spectrum of Kidney Ciliopathies 163
The Role of Artificial Intelligence in the Diagnosis and Prognosis of Renal Cell Tumors 163
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets 160
Role of DNA analysis and mutation of P53 gene in small dimension renal carcinomas. Biological significance and long-term follow-up 159
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy 159
Green fluorescent protein as indicator of non-viral transient transfection efficiency in endometrial and testicular biopsies 158
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies 158
[Gene p53 mutation and prognosis in bladder tumors]. 157
HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected andreogen-dependent and androgen-independent cancer. 156
Primary B-cell lymphoblastic lymphoma of the testis 156
2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections 155
The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review. 154
Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study. 154
An update on investigational therapies that target STAT3 for the treatment of cancer 154
alpha-methylacyl-CoA racemase (P504S)/34 beta E12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy 153
[Gleason's grading of prostatic cancer: a current perspective]. 153
[Interstitial cystitis: minimal diagnostic criteria]. 153
Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy 153
Oligometastases in Genitourinary Tumors: Recent Insights and Future Molecular Diagnostic Approach 153
Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. 152
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 152
Microbiome and cancers, with focus on genitourinary tumors 152
Atypical foci, suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy") 151
Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States 151
Active surveillance for low-risk prostate cancer. 150
Perivascular epithelioid cell tumor (PEC-ome) of the prostate: ultrasound feature in case report 150
Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer 150
[Adrenal metastasis: clinical and pathological aspects]. 149
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View 149
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 149
Metabolic Alterations in Renal and Prostate Cancer 148
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry 147
The role of obesity in renal cell carcinoma patients: Clinical-pathological implications 146
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer. 144
Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. 144
[The kidney in rheumatoid arthritis]. 144
Adipose cannabinoid CB1 receptor expression and adiponectin correlate with microvascular damage in human kidney 144
Bone targeting agents in patients with metastatic prostate cancer: State of the art 144
[Thin glomerular basement membrane disease]. 143
Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor 143
Molecular characterization of testicular germ cell tumors using tissue microdissection 142
Adjuvant therapy in renal cell carcinoma: Is it the right strategy to inhibit VEGF? 142
Diagnostic Criteria for Ductal Adenocarcinoma of the Prostate.Interobserver Variability among 20 Expert Uropathologists. 141
Do DNA methylation and histone acetylation play a role in clear cell renal carcinoma? Analysis of radical nephrectomy specimens in a long-term follow-up. 140
Effect of complete androgen blockade on pathologic stage and resection margin status of prostate cancer: Progress pathology report of the Italian PROSIT study 140
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review 140
[Quantitative microscopy in histopathology]. 139
2005 update on pathology of prostate biopsies with cancer 139
Genitourinary cancers: molecular determinants for personalized therapies 139
Is There a Role for Immunotherapy in Prostate Cancer? 139
Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network. 138
2009 update on the classification of renal epithelial tumors in adults 138
[Prostate biopsy: characteristics of the histological sample]. 138
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 138
PD-1 blockade therapy in renal cell carcinoma: current studies and future promises 138
An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer 138
The 1996 European Urology Focus on Preneoplastic Lesions of the Prostate 137
AT-rich interactive domain 1A (ARID1A) cannot be considered a morphological marker for prostate cancer progression: A pilot study 137
Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma. 136
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 136
MRI and pathological examination of post-mortem brains: the problem of white matter high signal areas. 135
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians 135
Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1 alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up 134
Karyometry in the early detection and chemoprevention of intraepithelial lesions. 134
Cytometric Evidence That Cervical Intraepithelial Neoplasia-i and Neoplasia-ii Are Dysplasias Rather Than True Neoplasias - An Image-analysis Study of Factors Involved In the Progression of Cervical Lesions 134
Urothelial lesions with inverted growth patterns: histogenesis, molecular genetic findings, differential diagnosis and clinical management 134
Totale 16.130
Categoria #
all - tutte 432.723
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 432.723


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.952 0 0 0 0 0 0 0 0 0 1.126 1.274 552
2021/20226.617 613 1.540 134 320 93 550 203 432 470 537 384 1.341
2022/202311.081 1.115 779 603 969 804 2.572 11 655 2.823 51 418 281
2023/20246.089 1.231 164 343 995 1.045 1.154 112 111 20 94 56 764
2024/202512.564 1.093 1.123 629 339 395 468 1.044 555 3.724 936 952 1.306
2025/202630.264 1.464 2.440 2.549 3.692 2.662 2.149 5.798 3.635 3.193 2.682 0 0
Totale 91.875